» Articles » PMID: 17950969

Can Serotonin Transporter Genotype Predict Serotonergic Function, Chronicity, and Severity of Drinking?

Overview
Specialty Psychiatry
Date 2007 Oct 24
PMID 17950969
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Serotonin transporter (5-HTT) activity is greater in carriers of the long (L) vs. short (S) alleles of the 5-HTT-linked polymorphic region (5'-HTTLPR) among healthy control subjects but not alcohol-dependent adults. In 198 alcoholics, we determined the relationship between current or lifetime drinking and platelet 5-HTT function and density among allelic variants of the 5'-HTTLPR. SS subjects were younger than L-carriers (LL and LS) (p<0.0085) and had fewer years of lifetime drinking. For L-carriers, the mean of Bmax for paroxetine binding, but not Vmax for serotonin (5-HT) uptake, was lower than that for SS subjects (p<0.05). More L-carriers than their SS counterparts had Vmax for 5-HT uptake below 200 nmol/10(7) platelets-min (p<0.05) and Bmax for paroxetine binding below 600 nmol/mg protein (p<0.06). Current drinking (drinks per day during the past 14 days) correlated positively with Km and Vmax of platelet 5-HT uptake (p<0.05) and negatively with Bmax, but not Kd, of paroxetine binding (p<0.05) for L-carriers alone. Years of lifetime drinking correlated negatively with Km and Vmax of platelet 5-HT uptake (p<0.05) and B(max), but not Kd, of paroxetine binding (p<0.05) for L-carriers alone. Among L-carriers alone, there were higher levels of platelet 5-HT uptake and lower levels of platelet paroxetine binding with increased drinking, and more lifetime drinking was associated with modestly lower levels of 5-HT uptake and paroxetine binding. Thus, 5-HTT expression varies with current and lifetime drinking in L-carriers alone.

Citing Articles

A randomized, double-blind, placebo-controlled, pharmacogenetic study of ondansetron for treating alcohol use disorder.

Seneviratne C, Gorelick D, Lynch K, Brown C, Romer D, Pond T Alcohol Clin Exp Res. 2022; 46(10):1900-1912.

PMID: 36055978 PMC: 9901168. DOI: 10.1111/acer.14932.


Validation of serotonin transporter mRNA as a quantitative biomarker of heavy drinking and its comparison to ethyl glucuronide/ethyl sulfate: A randomized, double-blind, crossover trial.

Cornell J, Conchas A, Wang X, Fink J, Chen H, Kane M Alcohol Clin Exp Res. 2022; 46(10):1888-1899.

PMID: 36031718 PMC: 9588643. DOI: 10.1111/acer.14931.


Pharmacotherapies and personalized medicine for alcohol use disorder: a review.

Lohoff F Pharmacogenomics. 2020; 21(15):1117-1138.

PMID: 32807012 PMC: 7586357. DOI: 10.2217/pgs-2020-0079.


Commentary: Targeting NMDA Receptor and Serotonin Transporter for the Treatment of Comorbid Alcohol Dependence and Depression.

Sari Y Alcohol Clin Exp Res. 2017; 41(2):275-278.

PMID: 28102547 PMC: 5272862. DOI: 10.1111/acer.13310.


Variation in the Serotonin Transporter Gene and Alcoholism: Risk and Response to Pharmacotherapy.

Thompson M, Kenna G Alcohol Alcohol. 2015; 51(2):164-71.

PMID: 26311211 PMC: 4755552. DOI: 10.1093/alcalc/agv090.


References
1.
Modai I, Malmgren R, Wetterberg L, Eneroth P, Valevski A, Asberg M . Blood levels of melatonin, serotonin, cortisol, and prolactin in relation to the circadian rhythm of platelet serotonin uptake. Psychiatry Res. 1992; 43(2):161-6. DOI: 10.1016/0165-1781(92)90130-u. View

2.
Heinz A, Goldman D, Gallinat J, Schumann G, Puls I . Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence. Psychopharmacology (Berl). 2004; 174(4):561-70. DOI: 10.1007/s00213-004-1903-x. View

3.
Gill K, Amit Z . Serotonin uptake blockers and voluntary alcohol consumption. A review of recent studies. Recent Dev Alcohol. 1989; 7:225-48. DOI: 10.1007/978-1-4899-1678-5_12. View

4.
Sander T, Harms H, Lesch K, Dufeu P, Kuhn S, Hoehe M . Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence. Alcohol Clin Exp Res. 1997; 21(8):1356-9. View

5.
Naranjo C, Knoke D . The role of selective serotonin reuptake inhibitors in reducing alcohol consumption. J Clin Psychiatry. 2001; 62 Suppl 20:18-25. View